InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Frazier Kenneth C, Autre. Insider active across 3 companies, notably Merck & Co., Inc.. In total, 9 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €1.7m. History available since 9 November 2021. The latest transaction was filed on 4 February 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Frazier Kenneth C
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
111,111 shares@ US$18.00100.0% of flowCommon StockSEC:0001193125-26-041555:0
Canonical exit: 5 May 2026 (T+90)
235,769 shares0Common StockSEC:0001127602-22-025118:0
235,000 shares0Common StockSEC:0001127602-22-025018:0
300,000 shares0Common StockSEC:0001127602-22-024871:0
567,084 shares0Common StockSEC:0001127602-22-024610:0
119,488 shares@ US$73.51100.0% of flowCommon StockSEC:0001127602-22-007005:0
2,500 shares0Common StockSEC:0001127602-22-000634:0
663,881 shares0Common StockSEC:0001127602-21-028802:0
2,500 sharesCommon StockSEC:0001127602-16-036237:0
9 of 9 declarations
About Frazier Kenneth C
FRAZIER KENNETH C is a declarant linked to Merck & Co., Inc., Exxon Mobil CORP, and Eikon Therapeutics, Inc., with the stated roles of Executive Chair at Merck & Co., Inc. and Director at Exxon Mobil CORP and Eikon Therapeutics, Inc. He has 9 filings in total, and across the 9 sampled recent filings, buy volume is EUR 1692598 and sell volume is EUR 0, with a date range from 2016-01-06 to 2026-02-06; the most common transaction nature is Option exercise.
